cellink

A crucial part of translating biomedical research and technology into space health means space crew will have to create their own functional cells, tissues, and even organs. Although the realization…

Taking a drug to market is a competitive, costly and challenging process involving preclinical laboratory and animal testing before the even more time-consuming and expensive four phases of human clinical…

Global bioprinting leader Cellink announced an agreement with the owners of Scienion AG, a German precision dispensing company, to acquire all company shares in an €80 million deal. Through this…

Startup Accelerator is an article series with a focus on new and exciting companies in the 3D printing space, in which 3DPrint.com speaks to startup leadership about their unique technologies…

Cellink partnered with Swiss medical technology manufacturer Kugelmeiers to offer a solution for more convenient and effective 3D cell culturing. The newly available Cellink Spheroid Kits combine Kugelmeiers’ Sphericalplate 5D…

Japanese researchers Jin Liu, Tatsuaki Tagami, and Tetsuya Ozeki have completed a recent study in nanomedicine, releasing their findings in “Fabrication of 3D Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local…

The unquestionably exciting field of 3D bioprinting is booming. It’s vibrant, determined, and sustained by a robust foundation of decades of research. Bioprinted organs aren’t yet being transplanted into human…

For over four years biotech company Cellink has been helping researchers pursue creative ways to promote organ regeneration, test novel drugs, develop vascularized bioconstructs, and more. Through collaborative partnerships and…

Finland is one of Europe’s most forested nations. Over 70 percent of the country’s boreal forest is covered with spruce, pine, downy birch, and silver birch. But beyond the splendor…

In only six years, Eric Gatenholm, along with his co-founding partner Hector Martinez, has moved from focusing on commercializing biotechnology startups to running one of the leading companies to offer…

The novel COVID-19 outbreak has altered the world at its core, transforming the foundation of most companies as economies begin to shut down to avoid a healthcare system collapse. In…

Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…

Seeking to strengthen their presence in Europe, 3D bioprinter provider and pioneer bioink company CELLINK, opened their new offices in Lyon, France, last October. Begining new partnerships and collaborations with…

Whenever the futuristic visions of the past are closer to becoming a reality we wonder what the next step for humanity will be. But when it comes to medicine, every…

Understanding cancer cells is a fundamental part of looking for ways to cure the disease, which has been around for a long time. Cancer is the second leading cause of…

CELLINK announced the latest product in their line of specialized bioprinting technology, the newly designed BIO X6, which can leverage up to six different intelligent printheads to fabricate constructs with…

Creating a sharing ecosystem for research projects in bioprinting is key to making scientific findings reproducible and enabling fellow scientists and engineers to contribute to the evergrowing biotechnology community worldwide.  With…

Bioprinting company CELLINK announced it has entered into an agreement with the owners of life science company cytena GmbH, of Germany, to acquire all of the company shares for a purchase…

To study the influence of microgravity and hypergravity on living systems, bioprinting pioneer CELLINK, in collaboration with a team of scientists at Uppsala University, has sent 3D bioprinted boundary cap…

Back in 2015, Erik Gatenholm realized there was no place to purchase bioink for 3D bioprinting. So, blown away by this gap in the market, he quickly worked with co-founder…

The realm of 3D printing operates on many levels, with those innovating in the medical arena constantly pushing more dynamic and complex processes forward via new hardware, 3D software, and…

According to the World Health Organization, cardiovascular disease is the number one cause of death globally. An estimated 17.9 million people died from cardiovascular disease in 2016, representing 31% of all…

3D bioprinting isn’t just about the quest to print working organs, although that is the goal of many in the field. But it also has many more immediate applications, such…

Arthroscopic surgery is a minimally invasive procedure, where the cartilage of a person’s damaged joint is examined and treated with an arthroscope – an endoscope inserted into the damaged joint through a…